Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Gastro Oesophageal Cancer × Capecitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Rectal Neoplasms 17 Colorectal Neoplasms 15 Breast Neoplasms 8 Colonic Neoplasms 6 Stomach Neoplasms 5 Pancreatic Neoplasms 5 Neoplasm Metastasis 4 Gallbladder Neoplasms 3 Bile Duct Neoplasms 3 Uterine Cervical Neoplasms 2 Esophageal Neoplasms 2 Anus Neoplasms 2 Anal Canal Carcinoma 2 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Somatostatinoma 1 Ovarian Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Lung Neoplasms 1 Liver Neoplasms 1 Kidney Neoplasms 1 Inflammatory Breast Neoplasms 1 Gastro Oesophageal Cancer 1 Central Nervous System Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Non-Small-Cell Lung 1 Carcinoma, Neuroendocrine 1 Carcinoma, Hepatocellular 1

Interventions

Oxaliplatin 1 Epirubicin 1 Docetaxel 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01710592 2013-01-10

ELECT

Cancer Trials Ireland

Phase 2 Completed

Gastrointestinal

Gastro Oesophageal Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡